The in vivo temporal changes of luciferase activity were investigated under the control of an hsp70 promoter in three tumour models after the application of different intensities of highintensity focused ultrasound (HIFU). Three cell lines, SCCVII, NIH3T3 and M21 were stably transfected with a plasmid containing the hsp70 promoter and luciferase reporter gene, and tumours were subcutaneously initiated into mice. At a size of 1300 ± 234 mm 3 , the tumours were exposed to five intensities of continuous HIFU (802-1401-2157-3067-4133 W/cm 2 ) for 20 sec. Bioluminescence and MR imaging were performed to assess luciferase activity and signal intensity changes in the tissue. The MRI scan protocol was pre-and post-contrast T1-wt-SE, T2-wt-FSE, DCE-MRI, diffusion-wt STEAM sequence, T2 relaxation time determination obtained on a 1.5-T GE MRI scanner. The NIH3T3 tumours showed the highest luciferase activity of 328.1 ± 7.1 fold at 24 h at a HIFU intensity of 3067 W/cm 2 , the M21 tumours of 3.2 ± 0.6 fold 8 hours and the SCCVII tumours 2.9 ± 0.9 fold 4 hours post-HIFU at 2157 W/cm 2 . The greatest increase in T2 signal intensity and T2 relaxation time of 20.7 ± 3.4% was seen in the SCCVII tumours. The highest contrast medium uptake of 10.1 ± 1.1%
Introduction
Heat shock proteins (Hsp) are thought to facilitate protein folding in response to different sources of stress (1). Investigation of the transcriptional activation of 70-kilodalton heat shock protein (hsp70 for the gene, and Hsp70 for the protein) in response to elevated temperatures including hyperthermal cell death have been performed within the scope of cancer therapy studies (2, 3) and burn injury studies (4, 5) . The induction of an hsp70 expression can be anywhere from a few folds to several orders of magnitude, as with the hsp70 promoter (6). These studies examined the response of cells to temperatures a few degrees above physiological levels (40°C-47°C) for periods of time ranging from a few minutes to a few hours.
It could be shown that ultrasound enhances transfection and therefore gene expression through the permeabilisation of cell membranes, facilitating the transfer of naked plasmid DNA into tumours and normal cells (7). However, ultrasound-mediated non-viral transfection enhancement of naked DNA is hardly beyond 20-fold (8), which appears too low for clinical applications. In such, it seems promising to investigate an alternative route of ultrasound-mediated gene expression, exploiting the ability of ultrasound to induce localised heating in conjunction with a heat inducible promoter (9). Here, in the context of a local induction of gene expression based on the hsp70 promoter, we concentrate on high-intensity focused ultrasound (HIFU) because of its unique non-invasive character. Spatial and temporal quantification of hsp70 promoter efficiency is possible by using bioluminescence imaging technology (10). MRI is a powerful modality in thermal treatments for assessing tissue changes taking place during and after therapy (11). It can be shown that post contrast T1-and T2-weighted imaging reveals signal intensity changes in treated tissue (12) . A further parameter which can be used to evaluate the effect of the thermal treatment of tissue is diffusion-weighted imaging. It is known that apart from chemical shifts and T1 proton relaxation, diffusion is also a temperature-sensitive parameter (13-15) .
In this study we combined bioluminescence and MR imaging in three different tumour models in order to observe gene expression patterns in these different tumour types, along with their correlation with MRI changes after the application of HIFU in a heat inducible manner. We used bioluminescence imaging as a measure of gene expression (16, 17) in three different tumour models exposed to five different HIFU intensities and assessed the T1, T2, DCE-MRI and diffusion changes in the tumour tissue. The physiologic changes that affect reporter gene expression under these HIFU conditions and their correlations with MRI are valuable in understanding therapeutic design in HIFU gene therapy applications.
Materials and Methods
All animal experiments were conducted in compliance with institutional animal care committee guidelines and with the approval of the animal care committee.
Reporter Construct
The heat shock reporter gene was constructed by amplifying the hsp70A1 promoter from mouse genomic DNA using polymerase chain reaction (PCR) (Genbank accession number M76613). The resulting 1926 base pair (bp) product containing the hsp70 promoter fragment was digested with the restriction enzymes Kpn I and Nco I, and ligated into the luciferase reporter plasmid pcDNA3.1(+) (Invitrogen, San Diego, CA) containing a selectable marker (neo r ).
Cell Culture and Transfection
Three tumour cells lines were used in this study. 
Tumour Implantation
Five animals were assigned to each experimental group. A control group of non-transfected tumour cells was used. Three animals were assigned to each control group. C3H/Km mice were used for initiating the SCCVII tumours and nude mice were used to initiate the M21 and NIH3T3 tumours. Animals were anaesthetised with intraperitoneal Nembutal (58 mg/kg), and their flank shaved and prepped with isopropyl alcohol. An average of 2 x 10 5 cells (in Hanks' solution) were used to initiate each tumour subcutaneously (s.c.) under the dorsal skin of the flank with a 27 G needle. The total volume of the injection was 0.2 ml. The sizes of the tumours were measured twice a week to monitor their growth. Approximately 2 to 3 weeks were required for tumours to grow to 1300 ± 234 mm 3 in size.
Animal and Experimental Setup
The mice were anaesthetised with intraperitoneal Nembutal (58 mg/kg) to induce deep anaesthesia. The mouse body was placed in a plastic tube with a window for positioning and treatment of the tumour. This tube was put in a deionised, degassed water bath to provide proper ultrasound coupling, which was heated up before the treatment to maintain proper body temperature. The dual ultrasound transducer was positioned in the same water bath (imaging 6 MHz/therapeutic 1 MHz) (Focus Surgery; Indianapolis, IN). The tumour was targeted with ultrasound imaging in its vertical and horizontal plane.
Focused Ultrasound System
A modified Sonoblate® system (Focus Surgery; Indianapolis, IN) was used for mechanistic studies. This system contains both imaging and therapy components in a single spherical and concave transducer. The therapy portion of the transducer has a frequency (f 0 ) of 1.0 MHz, aperture diameter of 50 mm, focal length of 40 mm, maximum total acoustical power of 120 W, and a maximum focal intensity in water of 8000 W/cm 2 . Focal area was 1.5 mm 2 , and electrical impedance magnitude at f 0 was 81 Ω. The imaging portion of the transducer has f 0 of 6.0 MHz, a bandwidth of 80 %, aperture diameter of 8 mm and focal length of 40 mm.
The sinusoidal wave signal was amplified by a 50 dB radiofrequency power amplifier (Agilent 33120A15 MHz function/ arbitrary waveform generator) coupled to the transducer device (50 Ω impedance). 
Bioluminescence Imaging
Bioluminescence imaging was performed with a highly sensitive, cooled CCD camera mounted in a light-tight specimen box (IVIS®, Xenogen) using protocols similar to those previously described (18). For in vivo imaging, animals were given the substrate D-luciferin by intraperitoneal injection at 150 mg/kg in PBS, and anaesthetised (1-3% isoflurane). Mice were placed onto the warmed stage inside the light-tight camera box with continuous exposure to 1-2% isoflurane. The animals were imaged on day one and two before HIFU application and every 4 hours for the first 12 hours followed by imaging every 12 hours for the next 48 hours, ending on day 8 after HIFU exposure. The data acquisition time was 30 sec. In previous experiments it was shown that this imaging time delivered the best results. The low levels of light emitted from the bioluminescent tumour cells were detected by the IVIS® camera system, integrated, digitised and displayed. Regions of interest surrounding the tumour area were designated in displayed images and quantified as total photon counts or photons/s using Living Image® software (Xenogen). Background bioluminescence in vivo was in the range of 1 × 10 4 photon counts or 1-2 × 10 5 photon/s.
MR Imaging
MR imaging was performed prior to HIFU application in order to get baseline results and after 8 hours, 48 hours and 96 hours following HIFU exposure to the tumours.
MR imaging was performed while the animal was inhaling an anaesthetic (1-3% isoflurane 
Image Analysis
Post-processing of the MR images was done using MRVI-SION (MRVision Co., Menlo Park, CA) version 1.5.4 b to analyse the tissue pixel intensities of the treated tumours.
For the semi-quantitative analysis, the mean signal intensities of the entire tumour and fat tissue were measured on the T2-wt FSE sequence and T1-wt SE sequence before and after administration of the contrast agent using a monitor-defined, circular region of interest (ROI) with 130-150 pixels for the whole tumour, and 30-35 pixels for the fat tissue. To measure signal intensity, an ROI was placed on the image containing the maximum cross-sectional area of each location. The size and location of the ROI were kept constant for measurements at different times. The signal-to-noise ratios (SNR) were calculated using the mean signal intensities of the areas and the SD of the background noise. After acquisition, DCE-MRI data were transferred to a personal computer for analysis. Data were analysed using MatLab 5.2 (The MathWorks, Inc., Natick, MA). A region of interest surrounding the entire tumour was manually selected. Time intensity curves were 
Statistical Analysis
Statistical analysis was performed using SPSS version 11.0 (SPSS, Chicago III). The mean bioluminescence (photon/s), SNR (T2), SNR (T1+CM), D x 10 -3 (mm 2 /s), T2 (ms), initial slope (% increase/min) and the Akep (/min) were expressed as mean ± SD. To test signal-to-noise ratio changes, changes in contrast kinetic variables, differences in the diffusion coefficient and the T2 relaxation time of the tumours at an applied HIFU intensity over time (in order to see if a specific HIFU intensity leads to a change in the parameter), the two-tailed Mann-Whitney U test with Bonferroni correction was used, where p ≤ 0.01 was considered to indicate statistical significance. The data from treated, non-transfected control groups were also analysed using the Mann-Whitney U test with Bonferroni correction (p ≤ 0.01).
Results

Bioluminescence Imaging
Different tumour types showed different luciferase activity under the control of the same hsp70 promoter. In addition, different energy levels of HIFU induced gene expression differentially, and this enhanced expression peaked at different times post-HIFU. However, it could be shown that parallel to increasing HIFU intensity, an increased induction of luciferase intensity was notable, which decreased with any further increase in HIFU intensity.
A HIFU exposure of 802 W/cm 2 did not induce the luciferase activity in the M21 and SCCVII tumours. However, the NIH3T3 tumours showed a significant induction (0.5 ± 0.1 fold increase over background) 12 hours post-HIFU. At a HIFU intensity of 1401 W/cm 2 a significant induction of the luciferase activity of 0.8 ± 0.6 fold (over background) was observed in the M21 tumours, peaking to a maximum at 12 hours post-HIFU. The NIH3T3 and SCCVII tumours showed a 4.8 ± 1.4 fold, and only a 0.2 ± 0.1 fold increased luciferase activity after 8 hours and 4 hours post-HIFU, respectively. At an intensity of 2157 W/cm 2 , the luciferase activity in the M21 tumours was the highest at 3.2 ± 0.6 fold 8 hours post-HIFU. In the NIH3T3 tumours, an induction of the luciferase activity of 146 ± 19 fold with a maximum at 8 hours was noted. In the SCCVII tumours, the highest luciferase activity of 2.9 ± 0.9 fold over background was observed at 4 hours post-HIFU exposure (Figure 1 ).
At an intensity of 3067 W/cm 2 and 4133 W/cm 2 , no induction of luciferase activity was seen in the M21 tumours, yet bioluminescence dropped to 0.6 ± 0.1 fold at 3067 W/cm 2 and 0.2 ± 0.02 fold at 4133 W/cm 2 . In the SCCVII tumours at an intensity of 3067 W/cm 2 and of 4133 W/cm 2 , a primary induction of the luciferase activity of 21.1 ± 5.1 analysed for each voxel in the image. The initial uptake slope was used to characterise the response to the bolus. Calculation of the initial slope used a five-point sliding linear regression applied to the first 2 minutes of the time intensity curve. A baseline signal intensity value, SI pre , was calculated as the mean intensity of three points before injection. The percentage increase per minute was then calculated according to Eq. A for each voxel.
%SI min = Slope SI pre .100
In addition, the analysis used a two-compartment model proposed by Hoffman et al. (19) based on that of Brix et al. (20) , which incorporates rate constants of Gd-DTPA between the lesion to plasma compartments (k ep ) and elimination by the plasma (k el ). The plasma concentration was not directly measured because the clearance rate (k el ) can be estimated from the measured tissue curve. After a bolus injection (τ = bolus duration), if k ep τ < 1 and k el τ < 1 are assumed then Hoffman's initial equation (19) reduces to Eq. B, which has three fitted variables: A (normalised amplitude), k ep (min -1 ), and k el (min -1 ).
The variables A and k ep , which describe the contrast transfer between the lesion and plasma compartments, are fit independently. At short intervals after injection (small values of t), the right side of Eq. B reduces to 1 + Ak ep t. The initial slope is thus proportional to Ak ep .
The diffusion coefficient and the T2-time of the tumour tissue before and after HIFU exposure were determined with MatLab 5.2 (The MathWorks, Inc., Natick, MA). In order to calculate the ADC and the T2 values, the spectroscopic data were apodised with a 10 Hz Lorentzian line broadening. After performing an FFT, a constant phase correction was applied to the individual spectra. Water and lipid signal intensities were calculated by peak integration in absorption mode within an interval of 200 Hz and 150 Hz, respectively. ADC and T2 values were calculated by fitting the peak intensities for the different b values and TEs, respectively, to a mono-exponential model.
Histology
The animals were euthanised at the end of the experiment and the treated tumour tissue was removed for histological analysis. For (H&E) staining, tissue samples were preserved in 10% formalin solution for 96 hours. They were then embedded in paraffin, sectioned, and stained with hematoxylin and eosin before being mounted on glass slides. tumours and 9.4 ± 3.3 x 10 3 photon/s in the non-transfected SCCVII tumours.
Combination of Bioluminescence and Magnetic Resonance Imaging
Combining the results of bioluminescence and MR imaging, it could be shown that with increasing HIFU intensity, significant changes in bioluminescence and MRI results were notable. At a low HIFU intensity, bioluminescence imaging showed no significant changes in the bioluminescence activity of M21 and SCCVII tumours, although a significant difference (p = 0.003) could be found in the NIH3T3 tumours. (Figure 2 ). In the control group of non-transfected tumours, bioluminescence activity lied significantly lower than the baseline luciferase activity of the transfected tumours. At a HIFU intensity of 802 W/cm 2 and 1401 W/cm 2 , no bioluminescence activity was seen in any of the non-transfected tumours. At an intensity of 2157 W/cm 2 , a bioluminescence activity of 1.3 ± 0.2 x 10 3 photon/s in the non-transfected M21 tumours, 2.1 ± 0.4 x 10 3 photon/s in the non-transfected NIH3T3 tumours and 3.3 ± 0.6 x 10 3 photon/s in the non-transfected SCCVII tumours could be found. It was found that bioluminescence activity increased parallel to increasing HIFU intensities. The highest bioluminescence activity was seen at an intensity of 4133 W/cm 2 4.5 ± 0.8 x 10 3 photon/s in the non-transfected M21 tumours, 6.8 ± 1.7 x 10 3 photon/s in the non-transfected NIH3T3 the M21 tumour cell line showed significant signal intensity changes. At the highest intensity differences, signal intensity changes of the T2-weighted images were seen in all tumour types. With increasing HIFU intensity, the T2 relaxation time also changed. This parameter is more sensitive than the signal changes of the T2 images. At the low HIFU intensity, no changes were seen in T2 relaxation. In the NIH3T3 and M21 tumours, significant T2 relaxation time changes were noted in the 8 h scan. Like the other MRI parameters, changes in the diffusion coefficient were seen at a HIFU intensity of 1401 W/cm 2 . The diffusion coefficient grew with increasing HIFU intensities in the M21 tumours, varying between 11.8 ± 2.5% (p = 0.009) at 1401 W/cm 2 and 19.4 ± 4.5% (p = 0.001) at 4133 W/cm 2 . In the NIH3T3 tumours, the lowest noted change in the diffusion coefficient varied between -2.9 ± 0.5% at 1401 W/cm 2 and 14.2 ± 0.5% at 2157 W/cm 2 in the 96 h scan. The greatest change was visible in the SCCVII tumours. At an intensity of 2157 W/cm 2 , the diffusion coefficient increased about 20.9 ± 4.1% (p = 0.008), climbing further to 40.3 ± 4.1% (p = 0.001) at an intensity of 3067 W/cm 2 in the 48 h scan (Tables I, II and III) .
at a HIFU intensity of 1401 W/cm 2 , increasing with growing HIFU intensity. However, only at the highest HIFU intensity of 4133 W/cm 2 was a significant difference notable in the T2 relaxation time in SCCVII tumours. A significant difference in contrast medium uptake was visible in the M21 tumours at different MRI time points, at a HIFU intensity between 1401 W/cm 2 and 4133 W/cm 2 . The highest uptake was seen at an intensity of 4133 W/cm 2 of 10.1 ± 1.1% (p < 0.01). In the NIH3T3 and SCCVII the HIFU intensity after the application of an intensity of 3067 W/cm 2 , a significant difference in contrast medium uptake was noted at the different scanning times: 15.0 ± 2.1% in the NIH3T3 tumours and 14.8 ± 1.9% in the SCCVII tumours at a HIFU intensity of 3067 W/cm 2 The slope of initial enhancement increased in the NIH3T3 tumours of 19.4 ± 2.3% (p < 0.01) at an intensity of 1401W/ cm 2 and decreased parallel to further HIFU intensity. At an intensity of 2157 W/cm 2 , the slope of the initial enhancement was not statistically different compared to the baseline results and varied between 0.9 ± 2.3% and 10.3 ± 2.1%. At an intensity of 3067 W/cm 2 , the slope of the initial enhancement was lower than the baseline results in all tumour types: -12.1 ± 2.1% (p < 0.01) in the M21 tumours and, not much lower, -10.1 ± 2.3% and -10.8 ± 2.8% in the SCCVII and NIH3T3 tumours, respectively. At an intensity of 4133 W/cm 2 , the slope of the initial enhancement was significantly lower than the baseline results in all three tumour types: -17.3 ± 4.1% in the M21 tumours, -22.8 ± 3.2% in the SCCVII tumours and -21.3 ± 3.6% in the NIH3T3 tumours ( Figure 4 ).
The Akep values increased at the lower HIFU intensities and decreased with further HIFU intensity. The highest values were seen at 39.7 ± 3.3% (p < 0.01) for the M21 tumours at a HIFU intensity of 1401W/cm 2 , 87.7 ± 4.1% (p < 0.01) for the SCCVII tumours and 71.5 ± 4.4% (p < 0.01) for the NIH3T3 tumours at a HIFU intensity of 2157 W/cm 2 . At a HIFU intensity of 4133 W/cm 2 , the Akep values were significantly lower than the Akep values of the baseline results in all tumour types: -51.2 ± 4.7% (p < 0.01) in the M21 tumours, -33.2 ± 3.9% (p < 0.01) in the SCCVII tumours and -26.7 ± 4.6% (p < 0.01) in the NIH3T3 tumours ( Figure 5 ).
Histology
At an intensity of 802 W/cm 2 , a small area of acute coagulation necrosis with condensation and pyknosis of nuclear chromatin and shrinkage could be seen along with hypereosinophilia of cell cytoplasm. Scattered throughout the remaining tissue were modestly increased numbers of individual necrotic cells as well as several small clusters of necrotic cells. With greater intensity, the area of coagulation necrosis increased. At an intensity of 4133 Table III Luciferase activity, SNR values, diffusion coefficient and T2 time in the SCCVII tumours exposed to different intensities of HIFU. Increasing HIFU intensities applied to the tumours led to significant differences in the evaluated parameters. The diffusion coefficient changed the most in SCCVII tumours, ranging from 34.1 ± 2.2% to 40.3 ± 3.6% after application of a HIFU intensity of 3067 W/cm 2 .
SCCVII_hsp70
Flux (photon/s) SNR ( W/cm 2 , a well demarcated region of severe coagulation necrosis could be seen with a sharp margin to the normal tissue ( Figure 6 ).
Discussion
Heat shock proteins are highly conserved and found in nearly all sub-cellular compartments (21, 22), where they perform a variety of chaperoning functions including antigen presentation (23) and protein folding/unfolding processes of nascent polypeptides and proteins (24). These functions may be important in the expression of thermotolerance (25) . In this study, we evaluated the effects of HIFU on tumours transfected with the Hsp70-luc/luciferase reporter gene. We used Focal signal intensity increase in the T2-weighted images due to tissue damage was noted ( ). After application of contrast medium, corresponding areas with a high signal intensity in the T2-weighted images showed a lack of contrast medium enhancement ( ). different intensities of HIFU and monitored gene expression levels and MRI changes in the tumour tissue.
It is known that HIFU causes physical changes in tissues through energy deposition. HIFU is used clinically for the thermal ablation of tumours (26). One further alternative to applying HIFU is to exploit the localised ability of ultrasound to induce gene expression using heat inducible promoters. It has been demonstrated that the promoter for heat-shock proteins (HSP) can activate gene expression in response to hyperthermia (27). With its low basal expression in combination with site-specific increased induction via HIFU, the hsp70 promoter allows expression levels to be readily modulated in a spatial and temporal manner. Our in vivo study has shown that the hsp70 promoter activity varies significantly in different tumour types. The ability to quantify gene expression in both a spatial and temporal fashion was possible by deploying bioluminescence imaging technology (10). Since luciferase activity can be measured in living cells (28) and tissues (29, 30) , imaging can provide a readout for any increases and decreases in transcription. This is an ideal method for real-time monitoring of gene transcription levels. The exact spatial and temporal pattern of gene expression induction using HIFU in each tissue type is important for clinical applications of this approach (31, 32). In our study, we were able to show that the pattern of gene expression varies in different tumour types. Hsp70A1-luc reporter construct activity was the highest in the NIH3T3 and M21 tumours with the most prolonged gene expression. Differences in the temporal gene expression between the tumour cell lines were visible. For example, at a HIFU intensity of 2157 W/cm 2 , the NIH3T3 and M21 tumours had the highest luciferase activity at 8 hours post-HIFU application, while this was seen after 4 hours in the SCCVII tumours.
This study showed that changes in the luciferase activity of transfected tumour cells are related to MRI changes such as T1 and T2 signal intensities, DCE-MRI parameters and changes in the diffusion coefficient of the different tumour types. However, these changes are tissue-dependent, meaning results cannot be transferred to another tissue type. These results show that significant cellular changes indicated by a high hsp70 expression lead to significant changes in T1 and T2 signal intensities. Extracellular compartments are significant determinants of the T1 and T2 signal intensity of tumours. The increase in signal intensity of the T2-weighted images is related to an increase of the extracellular compartment (33). It could be shown that T1 and T2 signal intensities are closed correlated with the fractionated water in tumours (34). The T1 and T2 values of tumours are mainly influenced by the ratio of free and structured water (35). Changes in the T1 and T2 values are caused by a change of this ratio. The increase of T1 and T2 values parallel to growing extracellular volume is probably combined with an increase in the ratio of free to structured and free to bound water (35). Our study showed that an increased hsp70 expression is related to an elevated portion of free extracellular water. At the lowest intensity of HIFU, no hsp70 expression or T2 changes were seen. With increasing intensity of HIFU to 3067 W/cm 2 , an increase was noted in the hsp70 expression and T2 changes. At the highest intensity of 4133 W/cm 2 , luciferase activity decreased, yet the T2 changes were the most pronounced indicating that the tissue was severely damaged. Aside from the T2 changes, the contrast medium uptake is an important feature for assessing biological changes in tumour tissue. An increased contrast medium uptake is mostly related to increased vascular permeability or an increase in vessel density (36). The T1 signal displayed a relative increase parallel to the increase in extracellular volume. Gd-DTPA has been shown to be a strong T1-shortener with little effect on T2, which is distributed in the extracellular compartment of tissues without significant penetration of the cell membrane (37). The results showed that the increased hsp70 expression is combined with a heightened contrast medium uptake in the tumour tissue. The change in signal intensity following contrast medium application varied significantly from that of the contrast medium uptake of the tumour tissue prior compartment model variable Akep. In theory, the constant A should depend only on the precontrast T1 of the tissues and be proportional to extravascular and extracellular space. In practice, however, it may depend on perfusion. Similarly, the variable kep is assumed to be more sensitive to vessel leakiness than A, although again in practice, its dependence of vascular volume and extracellular volume may limit its sensitivity. The two variables also depended on the tumour type and applied HIFU intensity. The slope of the initial enhancement did not statistically vary between the baseline results and the HIFU intensity of 2157 W/cm 2 . The Akep of the tumours increased between the baseline results and HIFU intensity of 2157 W/cm 2 , indicating a larger extravascular and extracellular space. With increasing HIFU intensity, the slope of initial enhancement and the Akep values decreased, indicating a reduction in tumour perfusion, vessel permeability or a combination of both. A decline in contrast medium uptake is mainly related to decreased vascular permeability or vessel density (39). The high intensity of HIFU leads to a coagulation of the tissue with decreased luciferase activity controlled by the hsp70 promoter. The change in signal intensity following contrast medium application was significantly different compared to the signal intensity of non-treated tumours. The increase of the diffusion coefficient is an indication that the tissue is less tight (40) and fewer diffusion obstacles like membranes, fibres, macromolecules or cell organelles exist, which can impair the mobility of water protons (41). The changed ratio of extracellular volume to intracellular volume, and the changed ratio of free to structured and free to bound water (42) were probably due to an increase in the diffusion coefficient. The normalisation of the diffusion coefficient in the 96 h and 192 h scan is an indication of tissue restructuring. At an intensity of 4133 W/cm 2 , the increase of the diffusion coefficient persisted in all three tumour types. The significant decrease of luciferase activity and significant increase of the diffusion coefficient might be related to tissue necrosis. Mannelli (43) evaluated diffusionweighted MRI with contrast-enhanced subtraction MRI in the assessment of the necrosis of hepatocellular carcinoma (HCC) following transarterial chemoembolisation (TACE). Compared to diffusion-weighted imaging, contrast-enhanced MRI with subtraction technique had a more significant correlation with the histopathologic findings in the evaluation of the necrosis of HCC after TACE. However, there was no difference between the two methods in the diagnosis of complete tumour necrosis. In necrotic tissue, a destruction of the cell membrane occurred with a reduction in tumour cell density, leading to an increase in the fractionated volume of the interstitial space and ultimately resulting in increased water mobility. These results correspond with theoretical and biological diffusion models, as well as with in vitro and in vivo studies (44, 45).
The results in our tumour model show that the diffusion changes are related to luciferase activity and, consequently, to the hsp70 transcription. This study is limited insofar as it to HIFU exposure in the three tumour types. The changes were not linear or dependent on the tolerance of the tissue. At an intensity of 4133 W/cm 2 , luciferase activity significantly decreased in all tumour types, indicating that the tissue was significant damaged (38). However, an increased contrast medium uptake was visible in the tissue. Contrast media currently available have a low molecular weight and can leak into the interstitial space of damaged tissue (37). Crossing the tolerance of the tissue, we could no longer find any correlation between luciferase activity and the T1 and T2 signal intensities of the tissue.
The tumour vascular function was assessed using an estimate of the initial slope of contrast agent uptake and the was not possible to perform thermometry in these tumours because a temperature probe in the tumour would harm the tissue and lead to unreliable bioluminescence and MR imaging results. In vitro studies by Hundt (46, 47) have shown that thermal and non-thermal effects like cavitation and the induction of radicals do induce gene expression of hsp70. However, in this in vivo experiment, we can not determine which effects dominate the expression of hsp70. One area of clinical use of HIFU application to tissue might be the opportunity to enhance hsp70 expression resulting in a higher HSP70 protein yield in the cells. This approach opens up the opportunity to selectively protect normal tissue against tumour toxic agents with low cellular specificity, such as radiation.
